Skip to main content
GLAUKOS Corp logo

GLAUKOS Corp — Investor Relations & Filings

Ticker · GKOS ISIN · US3773221029 LEI · 5299004JA1LHE21M6T14 US Manufacturing
Filings indexed 977 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country US United States of America
Listing US GKOS

About GLAUKOS Corp

https://www.glaukos.com

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company that develops and commercializes novel therapies for chronic eye diseases. The company focuses on advancing the standard of care for conditions such as glaucoma, corneal disorders, and retinal diseases. A pioneer in the field of Micro-Invasive Glaucoma Surgery (MIGS), Glaukos is committed to innovation through significant reinvestment in research and development to create transformative treatments. In addition to its product pipeline, the company provides comprehensive clinical support and educational resources for physicians to help integrate its technologies into their practices and improve patient outcomes.

Recent filings

Filing Released Lang Actions
8-K - GLAUKOS Corp (0001192448) (Filer)
Regulatory Filings
2026-05-04 English
8-K - GLAUKOS Corp (0001192448) (Filer)
Regulatory Filings
2026-04-29 English
ARS - GLAUKOS Corp (0001192448) (Filer)
Annual Report
2026-04-16 English
DEF 14A - GLAUKOS Corp (0001192448) (Filer)
Proxy Solicitation & Information Statement
2026-04-16 English
4 - GLAUKOS Corp (0001192448) (Issuer)
Director's Dealing
2026-03-28 English
4 - GLAUKOS Corp (0001192448) (Issuer)
Director's Dealing
2026-03-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.